Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chemicals, Inc., 61469-61470 [2015-25882]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 197 / Tuesday, October 13, 2015 / Notices
XIII. NO REACQUISITION
Defendants may not reacquire any
part of the Divestiture Assets during the
term of this Final Judgment.
XIV. RETENTION OF JURISDICTION
This Court retains jurisdiction to
enable any party to this Final Judgment
to apply to this Court at any time for
further orders and directions as may be
necessary or appropriate to carry out or
construe this Final Judgment, to modify
any of its provisions, to enforce
compliance, and to punish violations of
its provisions.
XV. EXPIRATION OF FINAL
JUDGMENT
Unless this Court grants an extension,
this Final Judgment shall expire ten (10)
years from the date of its entry.
mstockstill on DSK4VPTVN1PROD with NOTICES
XVI. PUBLIC INTEREST
DETERMINATION
Entry of this Final Judgment is in the
public interest. The parties have
complied with the requirements of the
Antitrust Procedures and Penalties Act,
15 U.S.C. 16, including making copies
available to the public of this Final
Judgment, the Competitive Impact
Statement, and any comments thereon
and the United States’ responses to
comments. Based upon the record
before the Court, which includes the
Competitive Impact Statement and any
comments and response to comments
filed with the Court, entry of this Final
Judgment is in the public interest.
Dated this l day oflll, 2015.
Court approval subject to procedures of
Antitrust Procedures and Penalties Act,
15 U.S.C. 16
llllllllllllllllll
l
United States District Judge
SCHEDULE A
List of products and functionality
included in ‘‘Divested Product,’’ as
defined in Section II.L of this Final
Judgment:
Dealertrack eCarList®;
Dealertrack AAX®;
Inventory+;
InventoryPro;
PriceDriver;
TrueTarget® (including TrueTarget®
Appraisal and TrueTarget® Pricing
Reports);
TrueTarget® Mobile;
Inventory+Mobile (including Inventory+
for iPhone® and Android);
Inventory Management Stocking and
Sourcing;
TrueScore;
Inventory+ Appraisal Workflow;
Inventory+ Merchandising;
AutoInk and eBay Listing and
Merchandising Tools (including
VerDate Sep<11>2014
21:23 Oct 09, 2015
Jkt 238001
integrated AutoInk description writer
and direct distribution to leading Web
sites such as backpage.com, Craigslist,
eBay Motors);
Dealer Web sites (eCarList only);
Dealertrack AutoReel® with
TruVoiceTM;
Inventory+ integrated, ‘‘multi-site’’ lead
Management system (including Email
Lead Management);
Dealertrack Interactive Automated
Incentives;
OutClickTM;
Inventory Health Report;
Lot Services;
PROShots;
Inventory+ New Car Pricing;
Dealertrack Inventory+ integration;
Inventory+ Multiplatform Listing;
Appraisal Central;
GroupTrade;
Software code for Inventory+ Exchange
(including Social Trade and
OpenTrade) and its predecessor
Dealertrack Marketplace;
Ability to enable Dealertrack
SmartChat® reporting within
Inventory+ for customers who have
both Inventory+ and SmartChat®; and
Fully integrated access and
interoperability with Broker
Connection.
[FR Doc. 2015–26042 Filed 10–9–15; 8:45 am]
BILLING CODE P
61469
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of methylphenidate (1724), a
basic class of controlled substance listed
in schedule II.
The company plans to import the
listed substance as a raw material for
updated testing purposes for EU
customer requirements.
The company plans to import the
listed controlled substances in finished
dosage form (FDF) from foreign sources
for analytical testing and clinical trials
in which the foreign FDF will be
compared to the company’s own
domestically-manufactured FDF. This
analysis is required to allow the
company to export domesticallymanufactured FDF to foreign markets.
Dated: October 2, 2015.
Louis J. Milione,
Deputy Assistant Administrator.
DEPARTMENT OF JUSTICE
[FR Doc. 2015–25881 Filed 10–9–15; 8:45 am]
Drug Enforcement Administration
BILLING CODE 4410–09–P
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Unither Manufacturing,
LLC
ACTION:
Unither Manufacturing, LLC
applied to be registered as an importer
of a certain basic class of controlled
substance. The Drug Enforcement
Administration (DEA) grants Unither
Manufacturing, LLC registration as an
importer of this controlled substance.
SUPPLEMENTARY INFORMATION: By notice
dated April 14, 2015, and published in
the Federal Register on April 22, 2015,
80 FR 22552, Unither Manufacturing,
LLC, 331 Clay Road, Rochester, New
York 14623 applied to be registered as
an importer of a certain basic class of
controlled substance. No comments or
objections were submitted for this
notice.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Unither Manufacturing, LLC to import
the basic class of controlled substance is
PO 00000
Frm 00136
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
[Docket No. DEA–392]
Notice of registration.
SUMMARY:
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: American
Radiolabeled Chemicals, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before December 14, 2015.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODXL, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
DATES:
E:\FR\FM\13OCN1.SGM
13OCN1
61470
Federal Register / Vol. 80, No. 197 / Tuesday, October 13, 2015 / Notices
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on August
10, 2015, American Radiolabeled
Chemicals, Inc., 101 Arc Drive, St.
Louis, Missouri 63146 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
mstockstill on DSK4VPTVN1PROD with NOTICES
Controlled substance
Schedule
Gamma
Hydroxybutyric
Acid
(2010) ........................................
Ibogaine (7260) ............................
Lysergic Acid diethylamide (7315)
Tetrahydrocannabinols (7370) ......
Dimethyltryptamine (7435) ...........
1-[1-(2Thienyl)cyclohexyl]piperidine
(7470) ........................................
Dihydromorphine (9145) ...............
Heroin (9200) ................................
Normorphine (9313) .....................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Amobarbital (2125) .......................
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Metazocine (9240) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273) ...............
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ....................
Phenazocine (9715) .....................
Carfentanil (9743) .........................
Fentanyl (9801) ............................
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances as radiolabeled compounds
for biochemical research.
VerDate Sep<11>2014
21:23 Oct 09, 2015
Jkt 238001
Dated: October 2, 2015.
Louis J. Milione,
Deputy Assistant Administrator.
Dated: October 2, 2015.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2015–25882 Filed 10–9–15; 8:45 am]
[FR Doc. 2015–25879 Filed 10–9–15; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
[Docket No. DEA–392]
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cambridge
Isotope Lab
ACTION:
Bulk Manufacturer of Controlled
Substances Application: Apertus
Pharmaceuticals
ACTION:
Notice of application.
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before December 14, 2015.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODXL, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on August
6, 2015, Apertus Pharmaceuticals, 331
Consort Drive, St. Louis, Missouri 63011
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
DATES:
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.33(a) on or before
December 14, 2015.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODXL, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated
her authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on August
7, 2015, Cambridge Isotope Lab, 50
Frontage Road, Andover, Massachusetts
01810 applied to be registered as a bulk
manufacturer of morphine (9300), a
basic class of controlled substance listed
in schedule II.
The company plans to utilize small
quantities of the listed controlled
substance in the preparation of
analytical standards.
DATES:
PO 00000
Frm 00137
Fmt 4703
Sfmt 4703
Controlled Substance
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Remifentanil (9739) ......................
E:\FR\FM\13OCN1.SGM
13OCN1
Schedule
I
I
II
]]>Agencies
[Federal Register Volume 80, Number 197 (Tuesday, October 13, 2015)]
[Notices]
[Pages 61469-61470]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-25882]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: American
Radiolabeled Chemicals, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes,
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before December 14, 2015.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODXL,
8701 Morrissette Drive, Springfield, Virginia 22152. Request for
hearings should be sent to: Drug Enforcement Administration, Attention:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
[[Page 61470]]
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on August
10, 2015, American Radiolabeled Chemicals, Inc., 101 Arc Drive, St.
Louis, Missouri 63146 applied to be registered as a bulk manufacturer
of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)............................. I
Ibogaine (7260).............................................. I
Lysergic Acid diethylamide (7315)............................ I
Tetrahydrocannabinols (7370)................................. I
Dimethyltryptamine (7435).................................... I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470)................. I
Dihydromorphine (9145)....................................... I
Heroin (9200)................................................ I
Normorphine (9313)........................................... I
Amphetamine (1100)........................................... II
Methamphetamine (1105)....................................... II
Amobarbital (2125)........................................... II
Phencyclidine (7471)......................................... II
Phenylacetone (8501)......................................... II
Cocaine (9041)............................................... II
Codeine (9050)............................................... II
Dihydrocodeine (9120)........................................ II
Oxycodone (9143)............................................. II
Hydromorphone (9150)......................................... II
Ecgonine (9180).............................................. II
Hydrocodone (9193)........................................... II
Meperidine (9230)............................................ II
Metazocine (9240)............................................ II
Methadone (9250)............................................. II
Dextropropoxyphene, bulk (non-dosage forms) (9273)........... II
Morphine (9300).............................................. II
Oripavine (9330)............................................. II
Thebaine (9333).............................................. II
Oxymorphone (9652)........................................... II
Phenazocine (9715)........................................... II
Carfentanil (9743)........................................... II
Fentanyl (9801).............................................. II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances as radiolabeled compounds for biochemical
research.
Dated: October 2, 2015.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2015-25882 Filed 10-9-15; 8:45 am]
BILLING CODE 4410-09-P
